Nanoparticle vaccines with novel structural components
US-12447206-B2 · Oct 21, 2025 · US
This page is not indexed by search engines while we improve data quality.
He Linling patents
He Linling is listed as an inventor on 35 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | He Linling |
| Total patents | 35 |
| First publication | Jan 3, 2019 |
| Latest publication | Oct 21, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Stabilized coronavirus spike (s) protein immunogens and related vaccines
US-12448416-B2 · Oct 21, 2025 · US
Compositions and methods related to hiv-1 immunogens
US-2025122247-A1 · Apr 17, 2025 · US
Stabilized hemagglutinin (HA) trimers as influenza vaccine antigens
US-12109261-B1 · Oct 8, 2024 · US
Stabilized coronavirus spike (s) protein immunogens and related vaccines
US-2024140993-A1 · May 2, 2024 · US
Compositions and methods related to hiv-1 immunogens
US-2024083954-A1 · Mar 14, 2024 · US
Compositions and methods related to ebolavirus vaccines
US-11872277-B2 · Jan 16, 2024 · US
Stabilized coronavirus spike (S) protein immunogens and related vaccines
US-11845777-B2 · Dec 19, 2023 · US
HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion envelope conformations
US-11767347-B2 · Sep 26, 2023 · US
Scaffolded hiv-1 vaccine immunogens
US-2023190910-A1 · Jun 22, 2023 · US
Recent patents
Latest publications not already listed above.
Methods and compositions related to hiv-1 nanoparticle vaccines with improved properties
US-2023181717-A1 · Jun 15, 2023 · US
Methods and compositions related to viral vaccines with improved properties
US-2023181718-A1 · Jun 15, 2023 · US
Engineered HCV E2 Immunogens and Related Vaccine Compositions
US-2023034467-A1 · Feb 2, 2023 · US
Compositions and methods related to ebolavirus vaccines
US-2022305109-A1 · Sep 29, 2022 · US
Scaffolded HIV-1 Env GP140 trimer immunogen
US-11452771-B2 · Sep 27, 2022 · US
Compositions and methods related to ebolavirus vaccines
US-11305004-B2 · Apr 19, 2022 · US
Compositions and Methods Related to HIV-1 Immunogens
US-2022098244-A1 · Mar 31, 2022 · US
Compositions and methods related to ebolavirus vaccines
US-2022040286-A1 · Feb 10, 2022 · US
Nanoparticle vaccines with novel structural components
US-2022031835-A1 · Feb 3, 2022 · US
Nucleic acids encoding HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion conformations
US-11236134-B2 · Feb 1, 2022 · US
Nanoparticle vaccines with novel structural components
US-11097002-B2 · Aug 24, 2021 · US
Engineered HCV E2 immunogens and related vaccine compositions
US-11008368-B2 · May 18, 2021 · US
Stabilized Coronavirus Spike (S) Protein Immunogens and Related Vaccines
US-2021139543-A1 · May 13, 2021 · US
Broadly neutralizing antibodies against HIV-1 and use thereof
US-10934345-B2 · Mar 2, 2021 · US
Novel Scaffolded HIV-1 Vaccine Immunogens
US-2021030884-A1 · Feb 4, 2021 · US
Stabilized coronavirus spike (S) protein immunogens and related vaccines
US-10906944-B2 · Feb 2, 2021 · US
Engineered HCV E2 Immunogens and Related Vaccine Compositions
US-2021024585-A1 · Jan 28, 2021 · US
Stabilized Coronavirus Spike (S) Protein Immunogens and Related Vaccines
US-2020407402-A1 · Dec 31, 2020 · US
Scaffolded HIV-1 vaccine immunogens
US-10780178-B2 · Sep 22, 2020 · US
Compositions and Methods Related to HIV-1 Immunogens
US-2020165303-A1 · May 28, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K39/12 | 33 |
| C07K14/005 | 28 |
| A61K2039/55555 | 23 |
| A61P31/18 | 21 |
| A61K39/21 | 19 |